ArticleJournal of the American Heart Association2019
Long-Term Comparison Between Pulmonary Homograft Versus Bioprosthesis for Pulmonary Valve Replacement in Tetralogy of Fallot.
Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.
- Efficacy and safety of mechanical pulmonary valve replacement: a comprehensive systematic review and meta-analysis.Journal of cardiothoracic surgery · 2025Pooled it
- Bovine pericardial versus porcine bioprosthetic valves in pulmonary position for adult congenital heart disease: A three-center, retrospective, propensity-weighted analysis of clinical outcomes.International journal of cardiology. Congenital heart disease · 2026Article
- Parameterized shape optimization of a bi-leaflet heart valved conduit for pediatric applications.Engineering with computers · 2026Article
- Investigating the Long-term Durability of Prosthetic Valves in Patients Who Have Undergone Tetralogy of Fallot Surgery with Transannular Patch.Interdisciplinary cardiovascular and thoracic surgery · 2025Article
- A novel decellularization protocol with cryopreservation of pulmonary allografts in an ovine model.Interdisciplinary cardiovascular and thoracic surgery · 2025Article
- Feasibility of minimally invasive pulmonary valve replacement with a novel mitral bioprosthetic valve associated with left atrial appendage resection.JTCVS techniques · 2025Article
- Allograft valves harvesting and preservation technique for enhanced performance.Cell and tissue banking · 2025Article
- Evolution of pulmonary artery reconstruction techniques: a focus on the neovalve from the right atrial appendage.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2025Article
- Immune Shielding of Human Heart Valves: A Proof-of-Concept Study of HLA-Targeting Therapy for Transplantations.JACC. Basic to translational science · 2024Article
- Last twenty-years activity of cardiovascular tissue banking in Barcelona.Cell and tissue banking · 2024Article
- Right Heart Remodeling After Pulmonary Valve Replacement in Patients With Pulmonary Atresia or Critical Stenosis With Intact Ventricular Septum.Journal of the American Heart Association · 2023Article
- Technical Recommendations for Computed Tomography Guidance of Intervention in the Right Ventricular Outflow Tract: Native RVOT, Conduits, and Bioprosthetic Valves.World journal for pediatric & congenital heart surgery · 2023Article
- Heterotopically-placed right ventricle-to-pulmonary artery conduit does not negatively affect outcomes.Journal of cardiothoracic surgery · 2023Article
- Pediatric pulmonary valve replacements: Clinical challenges and emerging technologies.Bioengineering & translational medicine · 2023Review
- Article
- Past, present, and future options for right ventricular outflow tract reconstruction.Frontiers in surgery · 2023Review
- Aortic-Valve Sparing Repair and Homograft and Dacron Pulmonary Reconstruction Long-term After Arterial Switch Operation.CJC pediatric and congenital heart disease · 2022Article
- Pulmonary valve neocuspidization and tricuspid valve replacement in intravenous drug abusers with infective endocarditis: Report of two cases.Interactive cardiovascular and thoracic surgery · 2022Article
- Pulmonary valve prostheses: patient's lifetime procedure load and durability. Evaluation of the German National Register for Congenital Heart Defects.Interactive cardiovascular and thoracic surgery · 2022Article
- Long-Term Comparison Between Pulmonary Homograft Versus Bioprosthesis for Pulmonary Valve Replacement in Tetralogy of Fallot.Journal of the American Heart Association · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
Abstract
Background Tetralogy of Fallot repair results in late occurrence of pulmonary regurgitation, which requires pulmonary valve replacement in a large proportion of patients. Both homografts and bioprostheses are used for pulmonary valve replacement as uncertainty remains on which prosthesis should be considered superior. We performed a long-term imaging and clinical comparison between these 2 strategies. Methods and Results We compared echocardiographic and clinical follow-up data of 209 patients with previous tetralogy of Fallot repair who underwent pulmonary valve replacement with homograft (n=75) or bioprosthesis (n=134) between 1995 and 2018 at a tertiary hospital. The primary end point was the composite of pulmonary valve replacement reintervention and structural valve deterioration, defined as a transpulmonary pressure decrease ≥50 mm Hg or pulmonary regurgitation degree of ≥2. Mixed linear model and Cox regression model were used for comparisons. Echocardiographic follow-up duration was longer in the homograft group (8 [interquartile range, 4-12] versus 4 [interquartile range, 3-6] years;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.